OAC
IPSC icon

OMERS Administration Corp’s Century Therapeutics IPSC Stock Holding History

OMERS Administration Corp’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-47,800
Closed -$108K – 1027
2026
Q1 		$108K Buy
+47,800
New +$101K ﹤0.01% 1007

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

OMERS Administration Corp's IPSC Position: Q2 2026 in Review

OMERS Administration Corp sold out of Century Therapeutics (IPSC) in Q2 2026, closing a stake of 47,800 shares — an estimated $108K sold.

OMERS Administration Corp first reported a position in IPSC in Q1 2026 and held it in 1 quarter. The position peaked at $108K in Q1 2026. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • OMERS Administration Corp reported no remaining Century Therapeutics position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 47,800 Century Therapeutics shares in Q2 2026, an estimated $108K.
  • OMERS Administration Corp first reported a position in Century Therapeutics in Q1 2026 and held it in 1 quarter.
  • OMERS Administration Corp's Century Therapeutics position peaked at $108K in Q1 2026.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.